{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T08:31:20Z","timestamp":1776069080041,"version":"3.50.1"},"reference-count":31,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T00:00:00Z","timestamp":1600732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Poly(lactic-co-glycolic acid) (PLGA) is one of the most successful polymers that has been used to produce medicines, such as drug carriers (DC) [...]<\/jats:p>","DOI":"10.3390\/pharmaceutics12090903","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T02:56:43Z","timestamp":1600916203000},"page":"903","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["PLGA Based Drug Carrier and Pharmaceutical Applications: The Most Recent Advances"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9841-3967","authenticated-orcid":false,"given":"Joana Ang\u00e9lica","family":"Loureiro","sequence":"first","affiliation":[{"name":"LEPABE, Department of Chemical Engineering, Faculty of Engineering of the University of Porto, s\/n, R. Dr. Roberto Frias, 4200-465 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8505-3432","authenticated-orcid":false,"given":"Maria Carmo","family":"Pereira","sequence":"additional","affiliation":[{"name":"LEPABE, Department of Chemical Engineering, Faculty of Engineering of the University of Porto, s\/n, R. Dr. Roberto Frias, 4200-465 Porto, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2020,9,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Makadia, H.K., and Siegel, S.J. (2011). Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier. Polymers, 3.","DOI":"10.3390\/polym3031377"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijpharm.2018.04.062","article-title":"Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment","volume":"545","author":"Ramalho","year":"2018","journal-title":"Int. J. Pharm."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1602\/neurorx.2.1.108","article-title":"Drug Transport to Brain with Targeted Nanoparticles","volume":"2","author":"Olivier","year":"2005","journal-title":"NeuroRX"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fphar.2018.01260","article-title":"PLGA-Based Nanoparticles in Cancer Treatment","volume":"9","author":"Rezvantalab","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.3762\/bjnano.6.135","article-title":"PLGA nanoparticles as a platform for vitamin D-based cancer therapy","volume":"6","author":"Ramalho","year":"2015","journal-title":"Beilstein J. Nanotechnol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Lu, B., Lv, X., and Le, Y. (2019). Chitosan-Modified PLGA Nanoparticles for Control-Released Drug Delivery. Polymers, 11.","DOI":"10.3390\/polym11020304"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Jose, S., Cinu, T.A., Sebastian, R., Shoja, M.H., Aleykutty, N.A., Durazzo, A., Lucarini, M., Santini, A., and Souto, E.B. (2019). Transferrin-Conjugated Docetaxel\u2013PLGA Nanoparticles for Tumor Targeting: Influence on MCF-7 Cell Cycle. Polymers, 11.","DOI":"10.3390\/polym11111905"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.colsurfb.2016.04.041","article-title":"Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer\u2019s disease treatment","volume":"145","author":"Loureiro","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1016\/j.vaccine.2017.05.094","article-title":"Immunogenicity of pulsatile-release PLGA microspheres for single-injection vaccination","volume":"36","author":"Guarecuco","year":"2018","journal-title":"Vaccine"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Shen, X., Li, T., Xie, X., Feng, Y., Chen, Z., Yang, H., Wu, C., Deng, S., and Liu, Y. (2020). PLGA-Based Drug Delivery Systems for Remotely Triggered Cancer Therapeutic and Diagnostic Applications. Front. Bioeng. Biotechnol., 8.","DOI":"10.3389\/fbioe.2020.00381"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Rigon, L., Salvalaio, M., Pederzoli, F., Legnini, E., Duskey, J.T., D\u2019Avanzo, F., De Filippis, C., Ruozi, B., Marin, O., and Vandelli, M.A. (2019). Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20082014"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Deng, M., Tan, J., Hu, C., Hou, T., Peng, W., Liu, J., Yu, B., Dai, Q., Zhou, J., and Yang, Y. (2020). Modification of PLGA Scaffold by MSC-Derived Extracellular Matrix Combats Macrophage Inflammation to Initiate Bone Regeneration via TGF- \u03b2 -Induced Protein. Adv. Heal. Mater., e2000353.","DOI":"10.1002\/adhm.202000353"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Ho, M.J., Jeong, H.T., Im, S.H., Kim, H.T., Lee, J.E., Park, J.S., Cho, H.R., Kim, D.Y., Choi, Y.W., and Lee, J. (2019). Design and In Vivo Pharmacokinetic Evaluation of Triamcinolone Acetonide Microcrystals-Loaded PLGA Microsphere for Increased Drug Retention in Knees after Intra-Articular Injection. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11080419"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Del Castillo, T., Ortega-Oller, I., Padial-Molina, M., O\u2019Valle, F., Galindo-Moreno, P., Jodar-Reyes, A.B., and Peula, J. (2019). Formulation, Colloidal Characterization, and In Vitro Biological Effect of BMP-2 Loaded PLGA Nanoparticles for Bone Regeneration. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11080388"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Minardi, S., Fernandez-Moure, J.S., Fan, D., Murphy, M.B., Yazdi, I.K., Liu, X., Weiner, B.K., and Tasciotti, E. (2020). Biocompatible PLGA-Mesoporous Silicon Microspheres for the Controlled Release of BMP-2 for Bone Augmentation. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12020118"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Garc\u00eda, P., Reyes, R., Segredo-Morales, E., Herrero, E., Delgado, A., and \u00c9vora, C. (2019). PLGA-BMP-2 and PLA-17\u03b2-Estradiol Microspheres Reinforcing a Composite Hydrogel for Bone Regeneration in Osteoporosis. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11120648"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Abuzar, S.M., Ahn, J.-H., Park, K.S., Park, E., Baik, S., and Hwang, S.-J. (2019). Pharmacokinetic Profile and Anti-Adhesive Effect of Oxaliplatin-PLGA Microparticle-Loaded Hydrogels in Rats for Colorectal Cancer Treatment. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11080392"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Kim, Y., Beck-Broichsitter, M., and Banga, A.K. (2019). Design and Evaluation of a Poly(Lactide-co-Glycolide)-Based In Situ Film-Forming System for Topical Delivery of Trolamine Salicylate. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11080409"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Duse, L., Agel, M.R., Pinnapireddy, S.R., Sch\u00e4fer, J., Selo, M.A., Ehrhardt, C., and Bakowsky, U. (2019). Photodynamic Therapy of Ovarian Carcinoma Cells with Curcumin-Loaded Biodegradable Polymeric Nanoparticles. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11060282"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Ramalho, M.J., Loureiro, J.A., Coelho, M.A.N., and Pereira, M.D.C. (2019). Factorial Design as a Tool for the Optimization of PLGA Nanoparticles for the Co-Delivery of Temozolomide and O6-Benzylguanine. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11080401"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Bazylinska, U., Kulbacka, J., and Chodaczek, G. (2019). Nanoemulsion Structural Design in Co-Encapsulation of Hybrid Multifunctional Agents: Influence of the Smart PLGA Polymers on the Nanosystem-Enhanced Delivery and Electro-Photodynamic Treatment. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11080405"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Varga, N., Turcs\u00e1nyi, \u00c1., Hornok, V., and Csap\u00f3, E. (2019). Vitamin E-Loaded PLA- and PLGA-Based Core-Shell Nanoparticles: Synthesis, Structure Optimization and Controlled Drug Release. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11070357"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Morelli, L., Gimondi, S.R., Sevieri, M., Salvioni, L., Guizzetti, M., Colzani, B., Palugan, L., Foppoli, A., Talamini, L., and Morosi, L. (2019). Monitoring the Fate of Orally Administered PLGA Nanoformulation for Local Delivery of Therapeutic Drugs. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11120658"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Janich, C., Friedmann, A., Silva, J.M.D.S.E., De Oliveira, C.S., De Souza, L.E., Rujescu, D., Hildebrandt, C., Beck-Broichsitter, M., Schmelzer, C.E., and M\u00e4der, K. (2019). Risperidone-Loaded PLGA\u2013Lipid Particles with Improved Release Kinetics: Manufacturing and Detailed Characterization by Electron Microscopy and Nano-CT. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11120665"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Ryu, W.M., Kim, S.-N., Min, C.H., and Bin Choy, Y. (2019). Dry Tablet Formulation of PLGA Nanoparticles with a Preocular Applicator for Topical Drug Delivery to the Eye. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11120651"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Andr\u00e9, E.M., Delcroix, G.J., Kandalam, S., Sindji, L., and Montero-Menei, C.N. (2019). A Combinatorial Cell and Drug Delivery Strategy for Huntington\u2019s Disease Using Pharmacologically Active Microcarriers and RNAi Neuronally-Committed Mesenchymal Stromal Cells. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11100526"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Garc\u00eda-Gabilondo, M., Rosell, A., and Roig, A. (2019). MRI\/Photoluminescence Dual-Modal Imaging Magnetic PLGA Nanocapsules for Theranostics. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12010016"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Feczk\u00f3, T., Piiper, A., Pleli, T., Schmithals, C., Denk, D., Hehlgans, S., R\u00f6del, F., Vogl, T.J., Wacker, M.G., and Denk, D. (2019). Theranostic Sorafenib-Loaded Polymeric Nanocarriers Manufactured by Enhanced Gadolinium Conjugation Techniques. Pharmaceutics, 11.","DOI":"10.3762\/bxiv.2019.1.v1"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Bakhaidar, R., Green, J., Alfahad, K., Samanani, S., Moollan, N., O\u2019Neill, S., Ramtoola, Z., and Neill, O. (2019). Effect of Size and Concentration of PLGA-PEG Nanoparticles on Activation and Aggregation of Washed Human Platelets. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11100514"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Operti, M.C., D\u00f6len, Y., Keulen, J., Van Dinther, E.A.W., Figdor, C.G., and Tagit, O. (2019). Microfluidics-Assisted Size Tuning and Biological Evaluation of PLGA Particles. Pharmaceutics, 11.","DOI":"10.20944\/preprints201910.0027.v1"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Shmool, T., Hooper, P.J., Schierle, G.S.K., Van Der Walle, C.F., and Zeitler, J.A. (2019). Terahertz Spectroscopy: An Investigation of the Structural Dynamics of Freeze-Dried Poly Lactic-co-glycolic Acid Microspheres. Pharmaceutics, 11.","DOI":"10.26434\/chemrxiv.7547222.v1"}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/12\/9\/903\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:12:31Z","timestamp":1760177551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/12\/9\/903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,22]]},"references-count":31,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["pharmaceutics12090903"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics12090903","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,22]]}}}